Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-09 GUYER DAVID R Director Grant or award · Stock Option (Right to Buy) +11,000 22,000
2022-02-09 DICICCO WENDY F Director Option exercise +2,500 4,400
2022-02-09 DICICCO WENDY F Director Option exercise · Restricted Stock Units −2,500 0
2022-02-09 DICICCO WENDY F Director Grant or award · Restricted Stock Units +3,000 3,000
2022-02-09 DICICCO WENDY F Director Grant or award · Stock Option (Right to Buy) +11,000 11,000
2022-02-09 ANDO GORAN Director Option exercise +2,750 4,900
2022-02-09 ANDO GORAN Director Grant or award · Restricted Stock Units +3,250 3,250
2022-02-09 ANDO GORAN Director Option exercise · Restricted Stock Units −2,750 0
2022-02-09 ANDO GORAN Director Grant or award · Stock Option (Right to Buy) +12,000 12,000
2022-02-09 Elston George Chief Financial Officer Option exercise +4,966 11,323
2022-02-09 Elston George Chief Financial Officer Shares withheld for taxes −1,721 $10.13 $17K 9,602
2022-02-09 Elston George Chief Financial Officer Option exercise · Restricted Stock Units −4,966 9,934
2022-02-09 Elston George Chief Financial Officer Grant or award · Restricted Stock Units +17,500 17,500
2022-02-09 Elston George Chief Financial Officer Grant or award · Stock Option (Right to Buy) +70,000 70,000
2022-02-09 Duker Jay S. Chief Operating Officer Option exercise +4,966 10,623
2022-02-09 Duker Jay S. Chief Operating Officer Grant or award · Restricted Stock Units +21,000 21,000
2022-02-09 Duker Jay S. Chief Operating Officer Option exercise · Restricted Stock Units −4,966 9,934
2022-02-09 Duker Jay S. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +85,000 85,000
2022-02-09 Paggiarino Dario A. Chief Medical Officer Option exercise +4,966 17,561
2022-02-09 Paggiarino Dario A. Chief Medical Officer Shares withheld for taxes −1,721 $10.13 $17K 15,840

Page 28 of 31 · 616 trades